BioLineRx Ltd. (BLRX)
3.09
-0.12 (-3.74%)
At close: Mar 13, 2025, 1:51 PM
BioLineRx Ltd. Income Statement
| Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | FY12 | FY11 | FY10 |
| Revenue | 4.8M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 113.16M | 113.16M | 63.91M | 31.89M |
| Cost of Revenue | 3.69M | 654K | 702K | 934K | 940K | 451K | 480.68K | 481.89K | 440.89K | n/a | n/a | n/a | 22.62M | 7.21M |
| Gross Profit | 1.11M | -654K | -702K | -934K | -940K | -451K | -480.68K | -481.89K | -440.89K | n/a | 113.16M | 113.16M | 41.29M | 24.69M |
| Operating Income | -49.69M | -29.16M | -24.78M | -22.93M | -28.11M | -25.61M | -25.24M | -16.51M | -16.2M | -15.85M | -17.63M | -21.83M | -15.41M | 3.7M |
| Interest Income | 2.01M | 694K | 559K | 236K | 777K | 719K | 1.17M | 480K | 457K | 3.28M | 746.59K | 2.36M | 3.34M | 861.33K |
| Pretax Income | -60.61M | -24.95M | -27.05M | -30.02M | -25.45M | -22.96M | -24.35M | -15.84M | -14.4M | -10.17M | -17.64M | -20.42M | 61.52M | 2.1M |
| Net Income | -60.61M | -18.87M | -28.14M | -30.93M | -26.81M | -18.51M | -24.35M | -15.84M | -14.4M | -10.17M | -17.64M | -20.42M | -13.19M | 2.1M |
| Selling & General & Admin | 31.23M | 11.53M | 5.27M | 4.68M | 4.59M | 5.77M | 5.73M | 5.31M | 4.65M | 4.95M | 4.86M | 4.57M | 4.21M | 5.44M |
| Research & Development | 12.52M | 17.63M | 19.47M | 18.17M | 23.44M | 19.81M | 19.51M | 11.18M | 11.49M | 10.9M | 12.65M | 17.21M | 11.2M | 15.49M |
| Other Expenses | 7.05M | 5.67M | 42K | 70K | 78K | 27K | -260K | 7K | 153K | 2.81M | -280.83K | -322.27K | 0.00 | 50.17K |
| Operating Expenses | 50.8M | 29.16M | 24.78M | 22.93M | 28.11M | 25.61M | 25.24M | 16.51M | 16.2M | 15.85M | 17.63M | 21.83M | 15.41M | 20.98M |
| Interest Expense | 2.17M | 2.16M | 984K | 1.47M | 1.83M | 21K | 21K | 14K | 15K | 411.67K | 20.67K | 25.96K | 1.12M | 16.63K |
| Selling & Marketing Expenses | 14.59M | 6.46M | 1M | 840K | 857K | 1.36M | 1.69M | 1.35M | 1M | 1.46M | 1.18M | 863.77K | 869.15K | 1.3M |
| Cost & Expenses | 54.49M | 29.16M | 24.78M | 22.93M | 28.11M | 25.61M | 25.24M | 16.51M | 16.2M | 15.85M | 17.63M | 21.83M | 15.41M | 28.19M |
| Income Tax | 1K | -6.08M | 1.09M | 911K | 1.36M | -4.46M | -888K | -672K | -1.8M | -5.68M | 15.79K | -1.42M | -2.22M | 1.61M |
| Shares Outstanding (Basic) | 963.37M | 773.96M | 662.93M | 252.84M | 146.41M | 108.6M | 89.97M | 56.14M | 51.41M | 32.43M | 22.49M | 16.94M | 12.36M | 12.35M |
| Shares Outstanding (Diluted) | 963.37M | 773.96M | 662.93M | 252.84M | 146.41M | 108.6M | 89.97M | 56.14M | 51.41M | 32.43M | 22.49M | 16.94M | 12.36M | 12.45M |
| EPS (Basic) | -0.06 | -0.02 | -0.04 | -0.12 | -0.18 | -0.17 | -0.27 | -0.28 | -0.28 | -0.31 | -0.78 | -1.21 | -1.07 | 0.17 |
| EPS (Diluted) | -0.06 | -0.02 | -0.04 | -0.12 | -0.18 | -0.17 | -0.27 | -0.28 | -0.28 | -0.31 | -0.78 | -1.21 | -1.07 | 0.17 |
| EBITDA | -57.06M | -28.5M | -25.35M | -21.99M | -27.17M | -25.15M | -23.83M | -15.34M | -13.94M | -10.79M | -16.7M | -19.38M | -13.59M | 4.21M |
| Depreciation & Amortization | 1.38M | 654K | 702K | 934K | 940K | 451K | 480.68K | 481.89K | 441K | 246.54K | 329.36K | 407.93K | 410.67K | 511.27K |